The human BTG2/TIS21/PC3 gene:: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene

被引:57
作者
Duriez, C
Falette, N
Audoynaud, C
Moyret-Lalle, C
Bensaad, K
Courtois, S
Wang, Q
Soussi, T
Puisieux, A
机构
[1] Ctr Leon Berard, Unite Oncol Mol, INSERM, U453, F-69373 Lyon 08, France
[2] Inst Curie Genotoxicol Tumeurs, F-75248 Paris, France
[3] Fac Pharm, F-69373 Lyon 08, France
关键词
BTG; promoter region; p53 binding site; breast cancer; mutation;
D O I
10.1016/S0378-1119(01)00825-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BTG2/TIS21/PC3 protein is involved in the regulation of G1/S transition of the cell cycle by inhibiting pRb function, suggesting that BTG2/TIS21/PC3 regulation is critical for normal cell growth and proliferation. To understand the regulatory mechanisms for the expression of BTG2/TIS21/PC3 we cloned the human gene. Potential binding sites for several transcription factors were identified in the 5'-flanking region of the gene. Transient expression assays with BTG2/TIS21/PC3 promoter deletions and electrophoretic mobility shift analysis identified a major wild-type p53 response element located -74 to -122 relative to the start codon. This genomic fragment was sufficient to constitute a promoter element in the presence of p53. The BTG2/TIS21/PC3 gene is an antiproliferative gene which maps within a chromosomal segment (1q32) frequently altered in breast adenocarcinomas. However, no mutations of BTG2/TIS21/PC3 were detected in breast cancer cells, suggesting that the inactivation of this gene is not a frequent genetic event during breast carcinogenesis. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:207 / 214
页数:8
相关论文
共 33 条
[1]   Regulation of the cell cycle by p53 after DNA damage in an amphibian cell line [J].
Bensaad, K ;
Rouillard, D ;
Soussi, T .
ONCOGENE, 2001, 20 (29) :3766-3775
[2]  
BORELLINI F, 1993, J BIOL CHEM, V268, P7923
[3]   Further characterisation of the p53 responsive element - Identification of new candidate genes for trans-activation by p53 [J].
Bourdon, JC ;
DeguinChambon, V ;
Lelong, JC ;
Dessen, P ;
May, P ;
Debuire, B ;
May, E .
ONCOGENE, 1997, 14 (01) :85-94
[4]   Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium [J].
Buanne, P ;
Corrente, G ;
Micheli, L ;
Palena, A ;
Lavia, P ;
Spadafora, C ;
Lakshmana, MK ;
Rinaldi, A ;
Banfi, S ;
Quarto, M ;
Bulfone, A ;
Tirone, F .
GENOMICS, 2000, 68 (03) :253-263
[5]  
Cortes U, 2000, MOL CARCINOGEN, V27, P57, DOI 10.1002/(SICI)1098-2744(200002)27:2<57::AID-MC1>3.0.CO
[6]  
2-I
[7]  
DEB SP, 1994, ONCOGENE, V9, P1341
[8]   P53 FUNCTIONS AS A CELL-CYCLE CONTROL PROTEIN IN OSTEOSARCOMAS [J].
DILLER, L ;
KASSEL, J ;
NELSON, CE ;
GRYKA, MA ;
LITWAK, G ;
GEBHARDT, M ;
BRESSAC, B ;
OZTURK, M ;
BAKER, SJ ;
VOGELSTEIN, B ;
FRIEND, SH .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) :5772-5781
[9]   Regulation of p53 downstream genes [J].
El-Deiry, WS .
SEMINARS IN CANCER BIOLOGY, 1998, 8 (05) :345-357
[10]   DEFINITION OF A CONSENSUS BINDING-SITE FOR P53 [J].
ELDEIRY, WS ;
KERN, SE ;
PIETENPOL, JA ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE GENETICS, 1992, 1 (01) :45-49